Strengthening pandemic readiness: South Africa's collaboration with Germany and the EU
Image: File
South Africa is reinforcing its leadership role in global pandemic preparedness through a major expansion of its genomic surveillance partnership with Germany and the European Union. The next phase of the Genomic Surveillance Project was officially launched on 24 June at the Centre for Epidemic Response and Innovation (CERI), Stellenbosch University's premier epidemic response institute based at its Tygerberg campus.
The project is a collaboration between CERI and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), under the broader SAVax Programme. SAVax is co-funded by Germany's Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU), and is implemented in partnership with South Africa's Department of Health and Department of Science, Technology and Innovation.
The new phase brings an additional R9 million in funding, bringing the total investment in the project to R12 million. This funding will allow CERI to continue surveillance of high-priority pathogens, including respiratory threats such as Avian Influenza H5N1 and emerging coronaviruses.
'South Africa is uniquely positioned to play this role,' said Katja Fuehrer, Specialist for Monitoring and Evaluation, Communication, and Commission Management at GIZ. 'The country has a strong industrial base, a highly skilled workforce, and some of the world's leading research institutions. With SAVax, we are tapping into those strengths to bolster Africa's ability to respond to future pandemics more independently and effectively.'
The first phase of the project, which ran from 2023 to 2024, sequenced over 1,000 pathogen genomes, trained more than 50 African scientists, and improved data-sharing protocols to support more effective outbreak responses. The new phase aims to scale these efforts even further by expanding genomic surveillance of respiratory pathogens, strengthening lab capacity in under-resourced provinces, and investing in the training of scientists at historically disadvantaged institutions in South Africa.
Establishing robust systems to monitor and analyse genetic information from pathogens helps South Africa to quickly detect and track changes in viruses proactively. This allows for faster responses to outbreaks and enhances pandemic preparedness in the country and the entire region.
Video Player is loading.
Play Video
Play
Unmute
Current Time
0:00
/
Duration
-:-
Loaded :
0%
Stream Type LIVE
Seek to live, currently behind live
LIVE
Remaining Time
-
0:00
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
Text Color White Black Red Green Blue Yellow Magenta Cyan
Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan
Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan
Transparency Transparent Semi-Transparent Opaque
Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps
Reset
restore all settings to the default values Done
Close Modal Dialog
End of dialog window.
Advertisement
Next
Stay
Close ✕
Ad loading
The launch event at CERI featured a tour of laboratories, a panel discussion, and a grant award ceremony attended by senior officials and diplomats.
'We are delighted to expand the collaboration with South Africa,' said Fulgencio Garrido Ruiz, EU Deputy Ambassador to South Africa. 'There is one aspect at the core of the approach which is research and development. A robust local research framework that enhances self-sufficiency and empowers nations to respond independently to health crisis.'
To date, the Team Europe Initiative MAV+ has mobilised more than 700 million euro's in South Africa, with 10 million euro's allocated to research infrastructure alone.
Sven Hartwig, Deputy Consul General at the German Consulate General in Cape Town, echoed this sentiment. 'It is an honour for the German cooperation to contribute to the Team Europe Initiative MAV+ and to work alongside dedicated partners like CERI,' he said.
'This launch highlights that surveillance for pandemic preparedness relies on partnership and collaboration between the public and private sectors, academia, and civil society. Germany is therefore particularly proud to continue supporting genomic surveillance and remains steadfast in its commitment to share global health goals.'
The launch event at the CERI Headquarters on Stellenbosch University's Tygerberg Campus included a tour of laboratories, a panel discussion and a grant award ceremony attended by senior officials and dignitaries.
Image: Stellenbosch University
Dr Anban Pillay, Deputy Director General from the National Department of Health, emphasised the local value of the initiative. 'The work of CERI and the University of Stellenbosch foster a culture of collaboration.'
Claudia Aguirre, head of the GIZ SAVax programme, underlined the importance of capacity building in this next phase of the partnership. 'In this new collaboration these capacity building efforts will be expanded. We look forward to supporting CERI in its journey to develop science on the African continent and contribute to the development of solutions by African scientists for Africa.'
The broader SAVax programme also aligns with the African Union's ambitious target to locally produce 60% of the continent's vaccines by 2040. By strengthening surveillance, vaccine development, and training programmes, the partnership aims to reduce Africa's dependency on imported vaccines and diagnostics.
'This partnership exemplifies how science, government, and international cooperation can come together to strengthen public health systems and respond more effectively to epidemic threats,' said Professor Tulio de Oliveira, Director of CERI. 'This is especially important for respiratory pathogens and new pathogens like Mpox, which have pandemic potential. The economic cost of a pandemic is so large that preventing it is a very wise and cost-effective investment.'
Fuehrer added that South Africa is now one of only two countries in the Southern Hemisphere conducting real-time genomic tracking of respiratory pathogens, a development that not only strengthens national capacity but fills critical global gaps.
'The data generated in South Africa is shared publicly through international databases, enabling the global health community to monitor pathogens, identify emerging threats, and refine pandemic preparedness,' said Fuehrer. 'It's about shifting the centre of gravity in global health — bringing Africa to the table not just as a recipient, but as a producer, a leader, and a partner.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
IOL News
3 days ago
- IOL News
Issues of trust, and a matter of time as South Africa begin vaccination of poultry
Astral, one of South Africa's top chicken producers, has been granted permission to start its virus immunisation program. As a first phase, only a small portion of Astral's stock—roughly 5% of the total—will be vaccinated. Image: File picture By Thabile Nkunjana On July 1st, 2025, the Department of Agriculture declared that the government would be starting its first-ever poultry industry vaccination program against highly pathogenic avian influenza (HPAI). Astral, one of South Africa's top chicken producers, has been granted permission to start its virus immunisation program. As a first phase, only a small portion of Astral's stock—roughly 5% of the total—will be vaccinated. According to data from the World Organisation for Animal Health (OAH), we are approaching the months when outbreaks often occur, thus the poultry sector has embraced this decision. The industry had recovered from the broiler side of things following the 2023 virus outbreak that caused a 30% reduction in industry flock and cost at least R9 billion, but the egg side is still recovering. Given that the virus outbreak is approaching its peak in terms of outbreaks, the poultry sector has applauded the move to vaccinate. However, even while the industry is pleased with the decision, many people are highly sceptical about it, and many have expressed their concerns on social media, including in a post by the agriculture minister. The primary concern is if eating items from a vaccinated bird is safe. The possibility that vaccination use could lead to mutations and resistance to the doses has also been raised on multiple occasions. Many countries around the world have already started utilising avian influenza vaccines after their poultry industries suffered severe economic setbacks and threatening livelihoods. Since 2005, vaccination against avian influenza has been used to prevent the infection in more than 30 countries globally. These include, among others, China, the world's largest egg producer, Mexico and Egypt to name some. Following the severity of the virus, which had a major impact on many countries in Europe like France, the European Union (EU-27), which is made up of 27 countries, started vaccination program in May 2023. It's also crucial to remember that a number of countries have yet to use the vaccines on poultry. These include the United States of America, the world's top exporter of live birds and a leading poultry producer, Brazil, the world's top exporter of poultry, and the United Kingdom. But according to recent reports, the United States is considering of implementing a vaccination program in response to the ongoing avian influenza outbreak there. There is reportedly a plan in place for possible utilisation. Additionally, Brazil has not been vaccinating because the viral outbreak there did not occur until lately. However, Brazil's agriculture minister has called for the discussion of vaccinations, which is a big step considering the Brazilians' prior concerns about this. As was previously noted, Brazil is the greatest poultry exporter in the world, and since they are afraid of trade limitations, they have been suspicious of vaccination in their poultry. However, they could as well end up vaccinating given the recent outbreak in Brazil. Especially in endemic and recently impacted areas, vaccination is an essential technique for reducing the impact and spread of infectious illnesses. Additionally, several countries throughout the world have previously implemented the vaccination that South Africa is starting for the past 19 years, and no proof has been offered about the risk or illnesses associated with consumption of vaccinated poultry. Also, vaccination is used to prevent diseases like rift valley fever, clostridial disease, and lumpy valley fever in cattle. Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated illness (PCVAD), Aujeszky's illness (Pseudorabies), and Classical Swine Fever are all prevented or controlled via vaccination programs for pigs. Meat and other products from animals, including beef and pork, are ingested because they are considered safe to eat and there are no reasons yet to doubt poultry consumption because of vaccination. It is fair to be concerned about immunisations. South Africa is part of a global trend towards greater consumer consciousness. Consumers are paying more attention to the origins of their food, the ingredients utilised in its production, and its manufacturing process. Research on poultry specifically indicates that roughly 30% of consumers in developed countries are willing to purchase this type of meat. However, the cost is a problem because this type of meat is typically pricey and is not produced to the scale other commercial poultry production is. Thabile Nkunjana is a senior economist under the Trade Research Unit at the National Agricultural Marketing Council. Image: LinkedIn * Thabile Nkunjana is a senior economist under the Trade Research Unit at the National Agricultural Marketing Council. ** He writes on his personal capacity, and does not, necessarily express of IOL or Independent Media.
IOL News
3 days ago
- IOL News
Strengthening pandemic readiness: South Africa's collaboration with Germany and the EU
This funding will allow CERI to continue surveillance of high-priority pathogens, including respiratory threats such as Avian Influenza H5N1 and emerging coronaviruses. Image: File South Africa is reinforcing its leadership role in global pandemic preparedness through a major expansion of its genomic surveillance partnership with Germany and the European Union. The next phase of the Genomic Surveillance Project was officially launched on 24 June at the Centre for Epidemic Response and Innovation (CERI), Stellenbosch University's premier epidemic response institute based at its Tygerberg campus. The project is a collaboration between CERI and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), under the broader SAVax Programme. SAVax is co-funded by Germany's Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU), and is implemented in partnership with South Africa's Department of Health and Department of Science, Technology and Innovation. The new phase brings an additional R9 million in funding, bringing the total investment in the project to R12 million. This funding will allow CERI to continue surveillance of high-priority pathogens, including respiratory threats such as Avian Influenza H5N1 and emerging coronaviruses. 'South Africa is uniquely positioned to play this role,' said Katja Fuehrer, Specialist for Monitoring and Evaluation, Communication, and Commission Management at GIZ. 'The country has a strong industrial base, a highly skilled workforce, and some of the world's leading research institutions. With SAVax, we are tapping into those strengths to bolster Africa's ability to respond to future pandemics more independently and effectively.' The first phase of the project, which ran from 2023 to 2024, sequenced over 1,000 pathogen genomes, trained more than 50 African scientists, and improved data-sharing protocols to support more effective outbreak responses. The new phase aims to scale these efforts even further by expanding genomic surveillance of respiratory pathogens, strengthening lab capacity in under-resourced provinces, and investing in the training of scientists at historically disadvantaged institutions in South Africa. Establishing robust systems to monitor and analyse genetic information from pathogens helps South Africa to quickly detect and track changes in viruses proactively. This allows for faster responses to outbreaks and enhances pandemic preparedness in the country and the entire region. Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Next Stay Close ✕ Ad loading The launch event at CERI featured a tour of laboratories, a panel discussion, and a grant award ceremony attended by senior officials and diplomats. 'We are delighted to expand the collaboration with South Africa,' said Fulgencio Garrido Ruiz, EU Deputy Ambassador to South Africa. 'There is one aspect at the core of the approach which is research and development. A robust local research framework that enhances self-sufficiency and empowers nations to respond independently to health crisis.' To date, the Team Europe Initiative MAV+ has mobilised more than 700 million euro's in South Africa, with 10 million euro's allocated to research infrastructure alone. Sven Hartwig, Deputy Consul General at the German Consulate General in Cape Town, echoed this sentiment. 'It is an honour for the German cooperation to contribute to the Team Europe Initiative MAV+ and to work alongside dedicated partners like CERI,' he said. 'This launch highlights that surveillance for pandemic preparedness relies on partnership and collaboration between the public and private sectors, academia, and civil society. Germany is therefore particularly proud to continue supporting genomic surveillance and remains steadfast in its commitment to share global health goals.' The launch event at the CERI Headquarters on Stellenbosch University's Tygerberg Campus included a tour of laboratories, a panel discussion and a grant award ceremony attended by senior officials and dignitaries. Image: Stellenbosch University Dr Anban Pillay, Deputy Director General from the National Department of Health, emphasised the local value of the initiative. 'The work of CERI and the University of Stellenbosch foster a culture of collaboration.' Claudia Aguirre, head of the GIZ SAVax programme, underlined the importance of capacity building in this next phase of the partnership. 'In this new collaboration these capacity building efforts will be expanded. We look forward to supporting CERI in its journey to develop science on the African continent and contribute to the development of solutions by African scientists for Africa.' The broader SAVax programme also aligns with the African Union's ambitious target to locally produce 60% of the continent's vaccines by 2040. By strengthening surveillance, vaccine development, and training programmes, the partnership aims to reduce Africa's dependency on imported vaccines and diagnostics. 'This partnership exemplifies how science, government, and international cooperation can come together to strengthen public health systems and respond more effectively to epidemic threats,' said Professor Tulio de Oliveira, Director of CERI. 'This is especially important for respiratory pathogens and new pathogens like Mpox, which have pandemic potential. The economic cost of a pandemic is so large that preventing it is a very wise and cost-effective investment.' Fuehrer added that South Africa is now one of only two countries in the Southern Hemisphere conducting real-time genomic tracking of respiratory pathogens, a development that not only strengthens national capacity but fills critical global gaps. 'The data generated in South Africa is shared publicly through international databases, enabling the global health community to monitor pathogens, identify emerging threats, and refine pandemic preparedness,' said Fuehrer. 'It's about shifting the centre of gravity in global health — bringing Africa to the table not just as a recipient, but as a producer, a leader, and a partner.'
IOL News
5 days ago
- IOL News
Cape Town launches new phase of the Genomic Surveillance Project
The launch event at the CERI Headquarters on Stellenbosch University's Tygerberg Campus included a tour of laboratories, a panel discussion and a grant award ceremony attended by senior officials and dignitaries. Image: Stellenbosch University Cape Town witnessed a significant step forward in public health as the new phase of the Genomic Surveillance Project was officially launched. A collaboration between the Centre for Epidemic Response and Innovation (CERI) at Stellenbosch University and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), this initiative aims to upscale the monitoring and analysis of genetic information from pathogens that pose a threat to public health. The project is part of the GIZ SAVax Programme, co-funded by the German Government, the Federal Ministry for Economic Cooperation and Development (BMZ), and the European Union (EU). The launch represents a concerted effort to strengthen local vaccine and pharmaceutical manufacturing in Africa, contributing to the Team Europe Initiative on manufacturing and access to vaccines, medicines, and health technologies (MAV+). The enhanced funding of R9 million marks an important milestone, bringing the total investment in this partnership to R12 million. This investment will bolster genomics surveillance, particularly targeting important pathogens, including respiratory threats such as Avian Influenza H5N1 and emerging coronaviruses. "This partnership exemplifies how science, government, and international cooperation can come together to strengthen public health systems and respond more effectively to epidemic threats,' said Professor Tulio de Oliveira, Director of CERI. Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Next Stay Close ✕ Ad loading The new phase of the Genomic Surveillance Project will build on existing progress with additional funding of R9 million, bringing total investment in the partnership to R12 million. Image: Stellenbosch University The launch event at the CERI Headquarters on Stellenbosch University's Tygerberg Campus featured a tour of laboratories, a panel discussion, and a grant award ceremony attended by senior officials and dignitaries. Mr. Fulgencio Garrido Ruiz, EU Deputy Ambassador to South Africa, expressed the importance of this collaboration: 'We are delighted to expand the collaboration with South Africa, especially as it plays a strategic role within the Team Europe Initiative MAV+.' The EU's MAV+ initiative has mobilised significant resources, including over €700 million for pandemic preparedness across the region, with €10 million directed specifically towards research infrastructure in South Africa. Garrido underlined the vision of enhancing self-sufficiency through local research frameworks to empower nations to independently tackle health crises. The emphasis on the collaborative aspect of health security was echoed by Sven Hartwig, Deputy Consul General of the German Consulate General, who stated, 'This launch highlights that surveillance for pandemic preparedness relies on partnership and collaboration between the public and private sectors, academia, and civil society.' Dr. Anban Pillay from the National Department of Health highlighted the cultural shift towards cooperation fostered by CERI and Stellenbosch University. Claudia Aguirre, head of the GIZ SAVax programme, remarked on the programme's role in bolstering capacity building and supporting African scientists in finding solutions tailored to the continent's unique health challenges. In the first phase of the CERI project, running from 2023-2024, over 1,000 pathogen genomes were sequenced, and more than 50 African scientists trained in genomic techniques. The second phase (2025-2026) will expand genomic surveillance efforts and promote the integration of data crucial for shaping public health policies. As South Africa takes on a pivotal role in global biosecurity, it becomes the second Southern Hemisphere nation, post-Australia, to provide real-time genomic tracking for winter disease pathogens Additionally, the project aims to strengthen laboratory infrastructure in under-resourced provinces while focusing on developing the careers of scientists from Historically Disadvantaged Universities.
